Search

everythinglearnresearchcommunity

for

Search:↓

SH-MSCs can improve hair growth by balancing gene expressions in fluconazole-related hair loss.

Thalidomide improved lupus symptoms but caused nerve damage in some patients.

Chemical lumbar sympathectomy is an effective and safe treatment for idiopathic livedo reticularis.

Metformin can help prevent the side effects of glucocorticoid medications on metabolism.

Epristeride's metabolism in zebrafish helps improve doping detection methods.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

The birth control pill containing ethinylestradiol and chlormadinone may help treat acne and other skin and hair conditions related to hormones.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Higher doses of spironolactone may improve acne in PCOS patients, but side effects are a concern.

Cyclosporin A is highly toxic to rats, causing severe health issues and death.

New compounds show promise as nonsteroidal treatments for hair loss.

All parts of the CLASI-A score are important for assessing skin activity in cutaneous lupus erythematosus.

Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Cyclosporin A promotes hair growth in young nude mice.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Cyclosporin effectively and safely treated skin diseases in three pets with no side effects.

Using nanostructured lipid carriers to deliver spironolactone could improve treatment for hair loss.

Oral contraceptives with desogestrel and drospirenone improve PCOS symptoms.

Combination therapy helped patient with advanced Hidradenitis Suppurativa achieve remission.

Deuruxolitinib is FDA-approved for treating severe alopecia areata.

Ozenoxacin reduces sebum production, helping manage acne.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Two finasteride tablet formulations are bioequivalent.

Etanercept effectively treated a severe skin condition when other treatments failed.